US pharma giant Pfizer on Wednesday told the central government that its Covid-19 vaccine is "highly effective" against the Covid-19 variant that is prevalent in India. Pfizer has also reportedly sought fast-track approval of its vaccine.
In a report, PTI said Pfizer presented data and told Indian authorities that its vaccine has shown "high effectiveness" against the variant prevalent in India and on people of Indian ethnicity or nationality.
Besides this, Pfizer added that its vaccine is also suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees.
Watch this video to know more.
A day after US President Donald Trump on Monday announced the landmark India-US trade deal and that he would reduce reciprocal tariffs from 25 per cent to 18 per cent, a massive political war has erupted in Delhi.
In an exclusive interview with India Today's Geeta Mohan and Marya Shakil, American journalist Tucker Carlson spoke on a wide range of issues, including the US-India trade deal and the role of social media.
This Get Real India report focusses on a horrific crime in Maharashtra's Nanded district, where a seven-year-old girl was allegedly murdered by her father to contest panchayat elections.
This edition of News Today focusses on the newly announced trade pact between India and the United States following a phone call between Prime Minister Narendra Modi and President Donald Trump.
